FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114781862> ?p ?o ?g. }

• W2114781862 endingPage "181" @default.
• W2114781862 startingPage "173" @default.
• W2114781862 abstract "Young women with polycystic ovary syndrome (PCOS) have a high risk of developing endometrial carcinoma. There is a need for the development of new medical therapies that can reduce the need for surgical intervention so as to preserve the fertility of these patients. The aim of the study was to describe and discuss cases of PCOS and insulin resistance (IR) women with early endometrial carcinoma while being co-treated with Diane-35 and metformin.Five PCOS-IR women who were scheduled for diagnosis and therapy for early endometrial carcinoma were recruited. The hospital records and endometrial pathology reports were reviewed. All patients were co-treated with Diane-35 and metformin for 6 months to reverse the endometrial carcinoma and preserve their fertility. Before, during, and after treatment, endometrial biopsies and blood samples were obtained and oral glucose tolerance tests were performed. Endometrial pathology was evaluated. Body weight (BW), body mass index (BMI), follicle-stimulating hormone (FSH), luteinizing hormone (LH), total testosterone (TT), sex hormone-binding globulin (SHBG), free androgen index (FAI), insulin area under curve (IAUC), and homeostasis model assessment of insulin resistance (HOMA-IR) were determined.Clinical stage 1a, low grade endometrial carcinoma was confirmed before treatment. After 6 months of co-treatment, all patients showed normal epithelia. No evidence of atypical hyperplasia or endometrial carcinoma was found. Co-treatment resulted in significant decreases in BW, BMI, TT, FAI, IAUC, and HOMA-IR in parallel with a significant increase in SHBG. There were no differences in the FSH and LH levels after co-treatment.Combined treatment with Diane-35 and metformin has the potential to revert the endometrial carcinoma into normal endometrial cells in PCOS-IR women. The cellular and molecular mechanisms behind this effect merit further investigation." @default.
• W2114781862 created "2016-06-24" @default.
• W2114781862 creator A5000451803 @default.
• W2114781862 creator A5020601619 @default.
• W2114781862 creator A5022526821 @default.
• W2114781862 creator A5051580376 @default.
• W2114781862 creator A5053339178 @default.
• W2114781862 creator A5068139862 @default.
• W2114781862 date "2014-01-01" @default.
• W2114781862 modified "2023-10-14" @default.
• W2114781862 title "Combination of Diane-35 and Metformin to Treat Early Endometrial Carcinoma in PCOS Women with Insulin Resistance" @default.
• W2114781862 cites W1527753191 @default.
• W2114781862 cites W1567678803 @default.
• W2114781862 cites W1577097214 @default.
• W2114781862 cites W1590256786 @default.
• W2114781862 cites W1967280785 @default.
• W2114781862 cites W1968812696 @default.
• W2114781862 cites W1969542174 @default.
• W2114781862 cites W1971464128 @default.
• W2114781862 cites W1971779058 @default.
• W2114781862 cites W1980498769 @default.
• W2114781862 cites W1998502987 @default.
• W2114781862 cites W2006340617 @default.
• W2114781862 cites W2009665800 @default.
• W2114781862 cites W2010355542 @default.
• W2114781862 cites W2016232075 @default.
• W2114781862 cites W2020942943 @default.
• W2114781862 cites W2022153701 @default.
• W2114781862 cites W2023298070 @default.
• W2114781862 cites W2026511467 @default.
• W2114781862 cites W2031482067 @default.
• W2114781862 cites W2035887422 @default.
• W2114781862 cites W2042858996 @default.
• W2114781862 cites W2053672725 @default.
• W2114781862 cites W2055402298 @default.
• W2114781862 cites W2057139536 @default.
• W2114781862 cites W2064424772 @default.
• W2114781862 cites W2067071255 @default.
• W2114781862 cites W2082521320 @default.
• W2114781862 cites W2088185348 @default.
• W2114781862 cites W2090228893 @default.
• W2114781862 cites W2095904930 @default.
• W2114781862 cites W2096234026 @default.
• W2114781862 cites W2103400524 @default.
• W2114781862 cites W2108512287 @default.
• W2114781862 cites W2108881204 @default.
• W2114781862 cites W2114069082 @default.
• W2114781862 cites W2119213719 @default.
• W2114781862 cites W2130638146 @default.
• W2114781862 cites W2139915659 @default.
• W2114781862 cites W2141842430 @default.
• W2114781862 cites W2156308377 @default.
• W2114781862 cites W2158675392 @default.
• W2114781862 cites W2160234571 @default.
• W2114781862 cites W2160472557 @default.
• W2114781862 cites W2166188229 @default.
• W2114781862 cites W2186218348 @default.
• W2114781862 cites W2294856982 @default.
• W2114781862 cites W2313448551 @default.
• W2114781862 cites W2316831615 @default.
• W2114781862 cites W2334361330 @default.
• W2114781862 cites W2363419772 @default.
• W2114781862 cites W2616656233 @default.
• W2114781862 cites W4214807362 @default.
• W2114781862 cites W77989090 @default.
• W2114781862 doi "https://doi.org/10.7150/jca.8009" @default.
• W2114781862 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3931265" @default.
• W2114781862 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24563672" @default.
• W2114781862 hasPublicationYear "2014" @default.
• W2114781862 type Work @default.
• W2114781862 sameAs 2114781862 @default.
• W2114781862 citedByCount "52" @default.
• W2114781862 countsByYear W21147818622014 @default.
• W2114781862 countsByYear W21147818622015 @default.
• W2114781862 countsByYear W21147818622016 @default.
• W2114781862 countsByYear W21147818622017 @default.
• W2114781862 countsByYear W21147818622018 @default.
• W2114781862 countsByYear W21147818622019 @default.
• W2114781862 countsByYear W21147818622020 @default.
• W2114781862 countsByYear W21147818622021 @default.
• W2114781862 countsByYear W21147818622022 @default.
• W2114781862 countsByYear W21147818622023 @default.
• W2114781862 crossrefType "journal-article" @default.
• W2114781862 hasAuthorship W2114781862A5000451803 @default.
• W2114781862 hasAuthorship W2114781862A5020601619 @default.
• W2114781862 hasAuthorship W2114781862A5022526821 @default.
• W2114781862 hasAuthorship W2114781862A5051580376 @default.
• W2114781862 hasAuthorship W2114781862A5053339178 @default.
• W2114781862 hasAuthorship W2114781862A5068139862 @default.
• W2114781862 hasBestOaLocation W21147818621 @default.
• W2114781862 hasConcept C126322002 @default.
• W2114781862 hasConcept C126894567 @default.
• W2114781862 hasConcept C134018914 @default.
• W2114781862 hasConcept C143998085 @default.
• W2114781862 hasConcept C2776405666 @default.
• W2114781862 hasConcept C2777391703 @default.
• W2114781862 hasConcept C2777546739 @default.
• W2114781862 hasConcept C2777689261 @default.

• next